Recurrent Basal Cell Carcinoma at a Prior Graft Margin
A 68-year-old man presents with a 1.4 cm pearly, telangiectatic nodule on the left nasal ala, present for 14 months. Seven years earlier he had a basal cell carcinoma at the same site treated by excision and full-thickness skin grafting; the graft is still visible. He is otherwise healthy, on no anticoagulants. He asks whether he can just have "the same surgery as last time." On examination the lesion is mobile, extends to within 2 mm of the alar rim, and there is no palpable cervical lymphadenopathy. Punch biopsy confirms nodular basal cell carcinoma, and pathology notes the tumor abuts the deep margin of the biopsy.
1. What features make this a high-risk tumor, and how do they affect your choice of treatment modality?
Read the worked answer
High-risk features here are: (1) location - nasal ala is H-zone, where recurrence is cosmetically and functionally costly and where tissue conservation matters; (2) recurrent tumor at a previously treated site, which is the single strongest predictor of further recurrence regardless of histology; (3) subclinical extension - recurrent tumors and those in embryonic fusion planes (nasal ala) commonly extend beyond visible margins, and a prior graft means the true scar and tumor bed may be wider than the visible lesion; (4) deep margin involvement on biopsy suggests dermal/surgical-bed extension. These features make destructive or narrow-margin modalities (curettage, cryotherapy, standard excision with 3-4 mm margins, or empiric radiotherapy) inappropriate: recurrence rates for recurrent nasal BCC after non-Mohs treatment are substantially higher than for primary tumors. Mohs micrographic surgery is the modality of choice because it gives complete margin control of the entire peripheral and deep edge, maximizes tissue conservation at the ala, and allows staged confirmation before reconstruction. The prior graft also means the surgical plane is scarred - Mohs lets you track tumor through scar and confirm clearance before committing to a repair.
2. The patient wants a single-stage procedure "like last time." How do you counsel him, and what does the prior graft imply for the Mohs layers and the reconstruction?
Read the worked answer
Counsel that the earlier operation removed a tumor with a fixed margin and did not verify the entire margin; a recurrence at that site indicates residual or new tumor in a scarred bed, and the safest approach is staged margin-controlled surgery. Explain the process: local anesthetic, a staged excision with frozen-section mapping, possible multiple stages, and repair the same day once clear (or delayed if clearance requires more stages or if a flap/graft is planned). Set expectations that the final defect may be larger than the visible lesion because tumor can track along the graft interface and scar. The prior graft implies: the dermis is replaced by scar and graft, so tumor may be found at the graft-host junction and deep to the graft; frozen sections must sample the entire mapped edge including scar; and the reconstruction will be more complex - a second graft or a local flap (e.g., nasolabial or bilobed) over a scarred bed has less predictable vascularity, so consider delayed repair or a flap with a reliable pedicle. Document the discussion and the patient's informed choice.